Trial Presented News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Trial Presented. Real-time updates on events, politics, business and more.

Key Takeaways from Phase 4 Switch Trial Presented at AAO

January 24, 2024

Richard Adler, MD, FACS, discusses the Switch trial which compared OTX-101 (cyclosporine ophthalmic solution 0.09%) vs cyclosporine ophthalmic emulsion 0.05% (Restasis) in patients with dry eye disease (DED).

Managing Dry Eye Disease Trial Presented Open Label Single Arm Study Incomplete Response Dry Eye Disease

Source: ajmc.com

Seagen Third Quarter 2023 Financial Results Reflect Strong Product Sales Growth, and Significant Portfolio and Pipeline Progress

November 1, 2023

-Record Net Product Sales of $571 Million in 3Q23, a 33% Increase Over 3Q22, Primarily Driven by PADCEV® First-Line Launch- -PADCEV with Keytruda® Potentially Practice Changing for First-Line...

United States David Epstein Roger Dansey Disitamab Vedotin Drug Administration Development Rd Expenses

Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Trial Presented News Today

Key Takeaways from Phase 4 Switch Trial Presented at AAO

Seagen Third Quarter 2023 Financial Results Reflect Strong Product Sales Growth, and Significant Portfolio and Pipeline Progress

Explore More Categories